TailorMed, an Israeli-based digital health company, has received US$40 million in equity and debt during its latest funding round.

Windham Capital Partners led the investment, with additional participation from Samsung Next, Citi Impact Fund, and BrightEdge Fund.

The funding comprised a US$12.5 million debt component led by Poalim Tech, bringing TailorMed’s total funding to US$69 million across three rounds.

The company addresses the affordability of prescription drugs, a critical concern in the United States where many adults face high treatment costs.

TailorMed’s platform facilitates connections between patients, healthcare providers, pharmacies, and pharmaceutical companies to help manage these expenses.